LABP — Landos Biopharma Share News
0.000.00%
Last trade - 00:00Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Super Micro, Micron Technology, Navios Maritime
U.S. STOCKS ON THE MOVE-Landos Biopharma, Foot Locker, US energy sector
Brief: AbbVie To Acquire Landos Biopharma
Deals of the day-Mergers and acquisitions
Landos Biopharma surges on buyout deal from AbbVie
AbbVie to bolster immunity illness drug pipeline with Landos deal (updated)
AbbVie to buy Landos to expand pipeline of immunity-related illnesses
Landos Biopharma Inc reports results for the quarter ended in December - Earnings Summary
Brief: Landos Biopharma Q4 Net Income USD -6.119 Million
Landos Biopharma Inc expected to post a loss of 91 cents a share - Earnings Preview
Brief: Landos Biopharma Q3 Net Income USD -5.86 Million
Brief: Landos Biopharma Says Patrick Truesdell Notified Of Intent To Resign As Vice President, Controller, Principal Accounting Officer
Landos Biopharma Inc reports results for the quarter ended in June - Earnings Summary
Brief: Landos Biopharma Q2 Net Income USD -3.922 Million
Landos Biopharma Inc expected to post a loss of $1.10 a share - Earnings Preview
Brief: Landos Biopharma Expands Board Of Directors With Appointment Of Alka Batycky
Brief: Landos Biopharma Announces 1-For-10 Reverse Stock Split
U.S. RESEARCH ROUNDUP-CTI Biopharma, Park National, Playags